A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model

Clinical Therapeutics

Volumn 23, Issue 7, 2001, Pages 1018-1031

  Daniels, Stephen E ^a   Grossman, Evie H ^b   Kuss, Michael E ^b   Talwalker, Sheela ^b   Hubbard, Richard C ^b  

^a Premier Research   (United States)

^b PFIZER INC   (United States)

Author keywords

Dental pain model; Ketorolac; Parecoxib; Post oral surgery

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; KETOROLAC TROMETAMOL; PARECOXIB; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL SURGERY; OSTEITIS; OTALGIA; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TOOTH EXTRACTION; VERTIGO;

EID: 0034894880     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80088-6     Document Type: Article

References (22)

1. Efficacy of nonsteroidal anti-inflammatory drugs in the management of postoperative pain
2. The efficacy of nonopioid analgesics for post-operative dental pain
3. Minimising the adverse effects of ketorolac
4. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
5. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: A postmarketing surveillance study
6. Cyclooxygenase in biology and disease
7. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
8. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs
9. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
10. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain
11. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
12. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
13. Correlation of pharmacokinetics (PK) with onset and duration of analgesia of intramuscular doses of parecoxib, in post-operative dental pain
14. Pharmacokinetic and efficacy evaluation of intravenous parecoxib in a postsurgical dental pain model
15. Single-dose analgesic studies: The upside and downside of assay sensitivity
16. Ketorolac and diclofenac for postoperative pain relief following oral surgery
17. Comparison of effect of intracanal use of ketorolac tromethamine and dexamethasone with oral ibuprofen on post treatment endodontic pain
18. The COX-2 specific inhibitor, parecoxib sodium, has analgesic efficacy when administered preoperatively
19. Single dose tolerability and pharmacokinetics of parecoxib sodium, a COX-2 specific inhibitor, following intramuscular administration
20. Single dose tolerability and pharmacokinetics of parecoxib sodium, a COX-2-specific inhibitor, following intravenous administration
21. The anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized, controlled trial
22. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults